Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-2771988_ITM" title="Facts and information about Melt in your mouth relief. (Products).">Melt in your mouth relief. (Products).</a>
Melt in your mouth relief. (Products).
OB GYN News
|
February 01, 2003 |
COPYRIGHT 2003 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright
Excedrin QuickTabs, headache relief tablets contain 500 mg acetaminophen and 65 mg caffeine, and can be taken without water. The spearmint or peppermint flavored tablets melt on the tongue, and come in ...
Related articles from newspapers, magazines, journals, and more

- BRISTOL-MYERS SQUIBB FILES CLAIMS AGAINST CANADIAN COMPANY FOR...
- Press release article from: PR Newswire July 5, 1995 700+ words
MONTREAL, July 5 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) today issued the following: Bristol-Myers Squibb and Bristol-Myers Squibb Canada Inc. today announced they have filed further claims in...

- BRISTOL-MYERS SQUIBB TAKES EQUITY POSITION IN IXSYS -- WILL FUND THREE-YEAR R&D...
- Press release article from: PR Newswire June 30, 1993 700+ words
...PRNewswire/ -- Ixsys, Inc. and Bristol-Myers Squibb Pharmaceutical Group announced today...signed an agreement in which Bristol-Myers Squibb will take an equity position in Ixsys...million in funding and gives Bristol-Myers Squibb a slightly more than 9 percent equity...

- Bristol-Myers Squibb Acquires Novel Oncology Drug From Manitoba Cancer...
- Press release article from: PR Newswire September 5, 1996 700+ words
...Sept. 5 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY), the Manitoba...license agreement under which Bristol-Myers Squibb will develop and market DPPE, a novel...the terms of the agreement, Bristol-Myers Squibb, the world leader in cancer chemotherapy...

- Bristol-Myers Squibb and N.J. Governor Whitman Dedicate Hopewell Research and...
- Press release article from: PR Newswire October 16, 1997 700+ words
...16 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) officials...executive officer of Bristol-Myers Squibb. "Today's dedication gives...occasion to reflect on Bristol-Myers Squibb's tradition of scientific excellence...

- Bristol-Myers Squibb, New Jersey Children's Hospital Launch Center for Immune...
- Press release article from: PR Newswire November 30, 2007 700+ words
...children with HIV/AIDS, Bristol-Myers Squibb Company today joined Robert Wood Johnson...new clinical center at The Bristol-Myers Squibb Children's Hospital at Robert Wood...infectious diseases. The Bristol-Myers Squibb Pediatric Infectious Disease and Immunology...

- Bristol-Myers Squibb And Sanofi File In The U.S. And Europe For Approval Of New...
- Press release article from: PR Newswire October 1, 1996 700+ words
...Oct. 1 /PRNewswire/ -- Bristol-Myers Squibb Company (NYSE: BMY) and Sanofi announced...II receptor antagonists. "Bristol-Myers Squibb takes great pleasure in joining with...executive vice president, Bristol-Myers Squibb Company, and president, Bristol...

- Bristol-Myers Squibb to Acquire Kosan Biosciences.
- Press release article from: Business Wire May 29, 2008 700+ words
Bristol-Myers Squibb Advances Company Strategy with Latest...and HAYWARD, Calif. -- Bristol-Myers Squibb Company (NYSE: BMY) and Kosan Biosciences...therapeutics company, by Bristol-Myers Squibb, for $5.50 per share in cash...

- Bristol-Myers Squibb & Phyton Agree to Commercialize Innovative Technology for...
- Press release article from: PR Newswire June 4, 1998 700+ words
...PRNewswire/ -- As part of Bristol-Myers Squibb Company's continuing quest to develop...anticancer drug TAXOL(R), Bristol-Myers Squibb (NYSE: BMY) and Phyton Inc. today...licensed this technology to Bristol-Myers Squibb exclusively in 1995. TAXOL is currently...

- Bristol-Myers Squibb Acquires Novel Antifungal From Eisai
- Press release article from: PR Newswire December 12, 1996 700+ words
...Spectrum Antifungal To Expand Bristol-Myers Squibb's Infectious Disease Franchise PRINCETON...Dec. 12 /PRNewswire/ -- Bristol-Myers Squibb (NYSE: BMY) announced today a licensing...the terms of the agreement, Bristol-Myers Squibb obtains an exclusive license worldwide...

- Bristol-Myers Squibb Announces Agreement in Principle to Resolve Federal...
- Press release article from: PR Newswire May 10, 2007 700+ words
...PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company and the Antitrust Division of...settlement agreement between Bristol-Myers Squibb, its product partner, sanofi-aventis...the agreement with the DOJ, Bristol-Myers Squibb, or a subsidiary of the company, will...
For more facts and information, see all results
Source: HighBeam Research, Melt in your mouth relief. (Products).